You are here: Industry Insights > expand

News List

GSK to invest $120m to expand manufacturing facility in US pharmaceutical-technology
September 27, 2019
GlaxoSmithKline (GSK) has committed $120m to expand its biopharmaceutical manufacturing facility in Upper Merion, Pennsylvania, US.
Biocon Biologics expands R&D footprint biospectrumasia
September 24, 2019
The financial details of the deal are confidential.Biocon Biologics has acquired these assets from Pfizer Healthcare India Ltd.
Parexel expands Ph I research capabilities in China biospectrumasia
September 19, 2019
Parexel recently was recognized as a leader in Phase I clinical development by Industry Standard Research in its 2019 CRO Quality Benchmarking Report. The company has eight offices and more than 1,700 employees across all functions in Greater China as wel
Pfizer commits $500m to expand gene therapy facility pharmaceutical-technology
August 23, 2019
Pfizer has announced plans to invest an additional $500m for the expansion of a gene therapy manufacturing facility in Sanford, North Carolina, US.
Berkshire Sterile Manufacturing Expands Capacity contractpharma
August 19, 2019
Berkshire Sterile Manufacturing (BSM), a fill/finish contract manufacturer providing formulation and sterile filling services for injectable medications, plans to add a third isolator line to expand capacity for future commercial clients.
Evotec Acquires Biotherapeutics contractpharma
July 04, 2019
$90M deal expands Evotec’s U.S. footprint in Seattle and machine learning capabilities.
AliveCor expands into Chinese Heart Health Market biospectrumasia
April 29, 2019
It is recommended by cardiologists and used by people worldwide for accurate ECG recordings
China moves to expand cancer medicine access biospectrumasia
March 11, 2019
Last October, the prices of 17 cancer drugs were slashed by an average of 56.7 percent following negotiations with drugmakers.
$10 million for ADHD medicine on the PBS firstwordpharma
February 23, 2019
The Liberal National Government will invest $10 million to expand access to a medicine for attention deficit hyperactivity disorder (ADHD).
FDA priority tag sets Roche's Tecentriq up for $1.5B expansion fiercepharma
December 10, 2018
Roche’s Tecentriq is closing in on a billion-dollar-plus lung cancer market that it can have all to itself.

Previous page 1 2 Next page